Table 1 Prevalence of hemoglobinopathies reported by previous studies in Kenya
Reference number | Prevalence | Author |
|---|---|---|
[10] | 18.7% for HbS (HbAS 17.1% and HbSS 1.6%) and 48.1% for α-thalassemia (heterozygous, 38.5% and homozygous 9.6%,) Western Kenya (in Kisumu County) | Suchdev et al. 2014 |
[11] | HbS prevalence of 19.9% (HbAS, 19.0% and HbSS, 0.9%) and 53.2% for α-thalassemia (heterozygous, 44.4% and homozygous, 8.8%) in hemoglobinopathies, Western Kenya (in Kisumu County) | Kifude et al. 2007 |
[7] | prevalence of 0.8% for sickle cell disease (HbSS heterozygotes,7.8% and HbSS homozygotes, 92.2%) plus 65.5% for α-thalassemia (heterozygous,48.6% and homozygous, 16.9%)-Kilifi County,(near Mombasa, Kenya’s Indian Ocean coast) | Uyoga et al. 2019 |
[12] | HbS prevalence of 31.8% (HbAS, 20.7% and HbSS, 11.1%) Western Kenya (in Kisumu County) | Kosiyo et al. 2020 |
[13] | HbS prevalence of 16.4% (HbAS 16.2%; HbSS, 0.2%) plus 48.2%, α-thalassemia (heterozygous, 40%, and homozygous, 8.2%)-Rural Western Kenya (Vihiga, Bungoma and Kakamega Counties | Byrd et al. 2019 |